INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique

Scitech Produtos Medicos SA80 enrolled

Overview

Evaluate the efficacy of the Inspiron Sirolimus Eluting Stent on bifurcation coronary artery lesions, in order to preserve and not compromize the side branch using the provisional stent technique.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Bifurcation Lesion Coronary Artery Disease

Interventions

Inspiron Sirolimus Eluting StentDEVICE

Bifurcation treatment using provisional stent technique

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with coronary artery disease on bifurcation anatomy with indication of drug eluting stent implantation , on which the side branch is ≥ 2.5 mm diameter and ostial stenosis ≤50% (Medina 1-1-0, 1-0-0, 0-1-0). Exclusion Criteria: * Acute Myocardial Infarction (STMI); * Chronic occlusion; * Cardiogenic shock; * Ejection fraction ≤ 20%; * Thrombocytopenia (≤ 50 mil); * DAPT contraindication; * Life expectancy of less than 12 months.

Locations (1)

Hospital Moinhos de Vento

Porto Alegre, Rio Grande do Sul, Brazil

RECRUITING

Outcomes

Primary Outcomes

Percentage of Stenosis

% of stenosis on side branch after stent placement on main vessel

Time frame: day 0

Central Contacts

Marco Wainstein, MD

CONTACT

+555133143537 marco.wainstein@hmv.org.br

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.